Accuray Incorporated · NASDAQ:ARAY
Accuray — Q1 FY2022 Earnings Presentation
12 slides from Accuray's earnings presentation, Nov 3, 2021
Slide 1: Q1'FY22 Earnings Call
Q1’FY22 Earnings Call November 3, 2021 Exhibit 99.2
Slide 2: Safe Harbor Statement
Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securiti
Slide 3: Executive Summary Q1'FY22
Executive Summary Q1’FY22 3 Proprietary and Confidential Property of Accuray Strong revenue performance with 26% Q1 Y/Y revenue growth Q1 ending backlog at $603M with 39% Q1 Y/Y order growth 3% net installed base growth Q1 Y/Y driving future recurring service and upgrade revenues Operating Expenses
Slide 4: Our Vision: To Expand the Curative Power of Radiation Therapy
4 Proprietary and Confidential Property of Accuray Our Vision: To EXPAND the CURATIVE POWER of RADIATION THERAPY to improve as many lives as possible Broader treatment options Beyond oncology Global patient access Enable advanced treatments Survival, long term outcomes Quality of life Precision tech
Slide 5: Strategy for Accelerating Revenue and Margin Expansion
5 Proprietary and Confidential Property of Accuray Strategy for Accelerating Revenue and Margin Expansion Financial model designed to both invest as well as grow the top line Reposition for Success Enhanced leadership team Established China joint-venture Introduced Synchrony Reset cost structure to
Slide 6: Global leader in SRS/SBRT: CyberKnife S7 and Radixact
6 Proprietary and Confidential Property of Accuray Global leader in SRS/SBRT Only robotic delivery system Fast <15 min treatments CYBERKNIFE® S7™ System 360-degree helical arc therapy IMRT and SBRT Fast <15 min treatments RRADIXACT® System Outstanding image quality Synchrony® 4D dynamic delivery VOL
Slide 7: Gross Order Performance by Region in Q1'FY22
7 Proprietary and Confidential Property of Accuray Gross Order Performance by Region in Q1’FY22 AMS 264% Q1 Y/Y EIMEA Flat Q1 Y/Y APAC 67% Q1 Y/Y JAPAN 28 % Q1 Y/Y +39% Q1 Y/Y Global Order Performance Note: Percentages above are calculated using actual dollars for Orders.
Slide 8: Q1'FY22 Financials
Q1’FY22 Financials Strong financial performance, Revenue guidance raised October 21st Proprietary and Confidential Property of Accuray KEY FINANCIAL METRICS $M Q1 Y/Y Highlights New product innovation driving order momentum Record fiscal first quarter revenue in Company history Raised FY22 full
Slide 9: In Summary
In Summary 9 Proprietary and Confidential Property of Accuray Entering Q2’FY22 With Accelerating Momentum Strongest Product Portfolio and Pipeline in Company’s History Multiple Growth Catalysts and Global Commercial Execution Strengthened Leadership Team and Operational Foundation Positioned for Acc
Slide 10: Thank You
10 Proprietary and Confidential Property of Accuray THANK YOU
Slide 11: GAAP to Adjusted EBITDA Q1 FY2022 and Q1 FY2021 Actual
11 Proprietary and Confidential Property of Accuray GAAP to Adjusted EBITDA Q1 FY2022 and Q1 FY2021 Actual Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA)
Slide 12: GAAP to Adjusted EBITDA FY2022 Guidance
12 Proprietary and Confidential Property of Accuray GAAP to Adjusted EBITDA FY2022 Guidance Projected Guidance Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA)